We initiated our study by employing the TISMO network tool, which revealed that cytokine therapy, particularly interferons (IFNβ and IFNγ), exhibited promising therapeutic effects in mouse models with high PSME3 expression, especially in various cancer types such as lung cancer, breast cancer, melanoma, and colorectal cancer (Figure 8A). Here, PSME3 is linked to lung cancer.